Literature DB >> 28820504

Diabetes: Insulin pumps after injections and CGM in T1DM.

John C Pickup1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28820504     DOI： 10.1038/nrendo.2017.108

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Insulin-pump therapy for type 1 diabetes mellitus.

Authors:  John C Pickup
Journal:  N Engl J Med       Date:  2012-04-26       Impact factor: 91.245

2.  Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Authors:  Roy W Beck; Tonya D Riddlesworth; Katrina J Ruedy; Craig Kollman; Andrew J Ahmann; Richard M Bergenstal; Anuj Bhargava; Bruce W Bode; Stacie Haller; Davida F Kruger; Janet B McGill; William Polonsky; David Price; Elena Toschi
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-12       Impact factor: 32.069

3.  Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

Authors:  Jan Bolinder; Ramiro Antuna; Petronella Geelhoed-Duijvestijn; Jens Kröger; Raimund Weitgasser
Journal:  Lancet       Date:  2016-09-12       Impact factor: 79.321

4.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Authors:  Marcus Lind; William Polonsky; Irl B Hirsch; Tim Heise; Jan Bolinder; Sofia Dahlqvist; Erik Schwarz; Arndís Finna Ólafsdóttir; Anders Frid; Hans Wedel; Elsa Ahlén; Thomas Nyström; Jarl Hellman
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

5.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Authors:  Roy W Beck; Tonya Riddlesworth; Katrina Ruedy; Andrew Ahmann; Richard Bergenstal; Stacie Haller; Craig Kollman; Davida Kruger; Janet B McGill; William Polonsky; Elena Toschi; Howard Wolpert; David Price
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

6.  Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.

Authors:  R Nixon; R Folwell; J C Pickup
Journal:  Diabet Med       Date:  2014-05-20       Impact factor: 4.359

7.  Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Authors:  Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman
Journal:  N Engl J Med       Date:  2013-06-22       Impact factor: 91.245

8.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Authors:  John C Pickup; Suzanne C Freeman; Alex J Sutton
Journal:  BMJ       Date:  2011-07-07

9.  Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.

Authors:  Pratik Choudhary; Birthe S Olsen; Ignacio Conget; John B Welsh; Linda Vorrink; John J Shin
Journal:  Diabetes Technol Ther       Date:  2016-02-23       Impact factor: 6.118

10.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Authors:  T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder
Journal:  Diabetologia       Date:  2012-09-11       Impact factor: 10.122
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.